References
- SEER Cancer Statistics Review, 1975 – 2003 [internet]. National Cancer Institute, Bethesda, MD 2005, Nov – Available from: http://seer.cancer.gov/csr/1975_2003/htm
- Phekoo K J, Richards M A, Moller H, Schey S A. The incidence and outcome of myeloid malignancies in 2112 adult patients in South East-England. Haematologica/Haematol J 2006; 91: 1400–1404
- Parkin D M, Whelan S L, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. V7. IARC Scientific Publications No. 143, LyonFrance 1997
- INCA – Instituto Nacional do Câncer. Câncer no Brasil: dados dos registros de base populacional. Ministério da Saúde. Rio de Janeiro 2003; 3, Brazil
- Taylor J A, Sandler D P, Bloomfield C D, Shore D L, Ball E D, Neubauer A, et al. ras Oncogene activation and occupational exposures in acute myeloid leukemia. J Natl Cancer Inst 1992; 84: 1626–1632
- Bennet J M, Catovsky D, Daniel M T, Flandrin G, Galton D AG, Gralnick H R, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Int Med 1985; 103: 626–629
- Bennet J M, Catovsky D, Daniel M T, Flandrin G, Galton D AG, Gralnick H R, et al. Proposal for the recognition of minimally diferentiated acute myeloid leukemia (AML-M0). Br J Haematol 1991; 78: 325–329
- Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into MRC AML 10 trial. Blood 1998; 92: 2322–2333
- Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison C J, et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia: analysis of 1065 patients entered into the United Kingdon Medical Research Council AML 11 trial. Blood 2001; 98: 1312–1320
- Jaffe E, Harris N, Stein H, Vardiman J. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Cap 4. IARC press, Lyon 2001
- Pulcheri W, Spector N, Nucci M, Morais J, Pimenta G, Oliveira H. The treatment of acute myeloid leukemia in Brazil: progress and obstacles. Haematologica 1995; 80: 130–135
- Rego M, Pinheiro G, Metze K, Lorand-Metze I. Acute leukemias in Piauí: comparison with features observed in other regions of Brazil. Braz J Med Biol Res 2003; 36: 331–337
- Douer D, Preston-Martin S, Chang E, Nichols P W, Watkins K J, Levine A M. High frequency of acute promyelocytic leukemia among latinos with acute myeloid leukemia. Blood 1996; 87: 308–313
- Pagnano K B, Traina F, Takahashi T, Oliveira G B, Rossini M S, Lorand-Metze I, et al. Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience. Sao Paulo Med J 2000; 118: 173–188
- Otero J C, Santillana S, Fereyros G. High frequency of acute promyelocytic leukemia among latinos with acute myeloid leukemia. Blood 1996; 88: 377, (letter)
- Tomás J F, Fernández-Rañada J M. About the increased frequency of acute promyelocytic leukemia among latinos: the experience from a center in Spain. Blood 1996; 88: 2357–2358, (letter)
- Pedersen-Bjergaard J, Philip P, Larsen S O, Jensen G, Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990; 76: 1083–1091
- Li C, Mang O, Foo W. Epidemiology of paediatric cancer in Hong Kong, 1982 to 1991. Hong Kong cancer registry. Hong Kong Med J 1999; 5: 128–134
- Ries L, Kosary C, Hankey B. Cancer Statistics Review, 1973 – 1996. National Cancer Institute, Bethesda 1999
- Mattsson B, Wallgren A. Completeness of the Swedish cancer register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol 1984; 23: 305–313
- Instituto Brasileiro de Geografia e Estatística (IBGE). Censo Demográfico do Brasil, [database on the internet] Rio de Janeiro, 2000. [cited 2005 Aug 5]. Available from: http://www.sidra.ibge.gov.br